Clinical studies of hormone replacement therapy to prevent cardiovascular d
iseases have heightened interest in the cardiovascular effects of progestin
s. However, the role of the progesterone receptor (PR) in vascular biology
has not been studied in vivo. We studied ovariectomized female PR knockout
(PRKO) mice and their wild-type (WT) littermates using the mouse carotid ar
tery injury model. Placebo-treated PRKO mice showed significantly greater v
ascular medial hypertrophy and vascular smooth muscle cell (VSMC) prolifera
tion in response to vascular injury than did WT mice. Progesterone had no s
ignificant effect in the PRKO mice, but worsened the response to injury in
WT mice. VSMCs cultured from PRKO mouse aortae were markedly hyperprolifera
tive, and their growth was not affected by progesterone. In contrast to the
in vivo findings, progesterone inhibited proliferation of WT-derived VSMCs
. Furthermore, reintroduction of PR into PRKO-derived VSMCs using adenovira
l methods restored progesterone-mediated inhibition of proliferation to the
se cells. This effect was reversed by the PR antagonist, RU 486. Thus, the
effects of PR and progesterone differ markedly between cultured VSMCs and i
ntact blood vessels. These data demonstrate a direct role for the PR in reg
ulating the response to vascular injury and VSMC proliferation.